Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trialAlessandro Gronchi, Paolo G. Casali, Stefano Ferrari et al.|The Lancet Oncology|2017Cited by 493
Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS): long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma GroupAlessandro Gronchi, Piero Picci, Silvia Stacchiotti et al.|Annals of Oncology|2016Cited by 132
Predicting Survival in Patients Undergoing Resection for Locally Recurrent Retroperitoneal Sarcoma: A Study and Novel Nomogram from TARPSWGChandrajit P. Raut, Alessandro Gronchi, Dario Callegaro et al.|Clinical Cancer Research|2019Cited by 116
Stereotactic body radiation therapy for lung metastases from soft tissue sarcomaPierina Navarria, Marta Scorsetti, A.M. Ascolese et al.|European Journal of Cancer|2015Cited by 98
Preoperative chemo-radiation therapy for localised retroperitoneal sarcoma: A phase I–II study from the Italian Sarcoma GroupAlessandro Gronchi, Paolo G. Casali, Antonino De Paoli et al.|European Journal of Cancer|2013Cited by 92